POC Medical Systems Inc.

POC Medical Systems Inc., founded in 2013 by Sanjeev Saxena, operates in the medical diagnostics market with a focus on point-of-care testing solutions. The company was established to address two primary challenges in medical diagnostics: geographic inaccessibility and cost. The firm secured significant funding, including a Series A round of $21 million in January 2017, part of a total of $22.1 million raised over two rounds, to fuel its development and growth. While headquartered in Livermore, California, the company's initial market focus was India, where traditional screening methods are not widely accessible. One source indicates the company is now considered deadpooled as of mid-2025.

The company's core technology is the Pandora CDx™ Point-of-Care System, a microfluidic platform designed for rapid serum screening. This system functions as a portable "lab-in-a-box," using a low-cost, disposable microfluidic compact disc to conduct tests. The process is automated, using centrifugal force to separate reagents after a blood sample is introduced, with an optical system detecting and measuring the concentration of specific analytes. The platform is designed to be operated by non-medical personnel with minimal training and can process multiple patients simultaneously. Test data is stored on a mobile tablet and uploaded to the cloud, allowing remote access for healthcare professionals.

The first product launched on this platform was the MammoAlert™ test, a blood-based screening tool for breast cancer. Requiring only a few drops of blood from a finger prick, the test analyzes multiple cancer biomarkers to generate a result in approximately 30 minutes. This multiplexed immunoassay was developed to offer a more accessible and affordable pre-screening alternative to mammograms, especially in regions with limited healthcare infrastructure. The business model appears to be based on the sale of the Pandora CDx™ instruments and the disposable, single-use MammoAlert™ test discs.

Keywords: point-of-care diagnostics, breast cancer screening, microfluidics, medical devices, in-vitro diagnostics, Pandora CDx, MammoAlert, blood-based test, serum screening, diagnostic platform, remote diagnostics, cloud-based healthcare, accessible healthcare, low-cost diagnostics, cancer biomarkers, immunoassay, Sanjeev Saxena, medical technology, rapid diagnostics, mobile health